Risk of conversion to bipolar disorder in patients with late-onset major depression.


Journal

International clinical psychopharmacology
ISSN: 1473-5857
Titre abrégé: Int Clin Psychopharmacol
Pays: England
ID NLM: 8609061

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 3 8 2022
medline: 12 10 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

To evaluate the impact of age at onset on late-life depression course and on risk of conversion to bipolar disorder (BD). A retrospective chart review of 100 elderly patients (age ≥ 65 years) diagnosed with a moderate-to-severe depressive episode and followed up for at least 18 months was conducted. Among patients affected by major depressive disorder ( N = 57), follow-up morbidity differences between those with typical onset depression (TOD) (<60 years) and those with late-onset depression (LOD) (≥60 years) were investigated using Wilcoxon rank-sum test and Cox proportional hazard model. Patients belonging to the LOD group had a significantly lower percentage of follow-up time spent with depressive symptoms compared with patients with TOD ( r = 0.36; P = 0.006), but significantly more time spent with (hypo)manic episodes ( r = -0.31; P = 0.021). Moreover, LOD was significantly associated with a faster conversion to BD (hazard ratio = 3.05; P = 0.037). Depression first emerging in late life may represent an unstable condition with a high risk to convert to BD. Given the potential clinical implications, further studies on the course of LOD are required.

Identifiants

pubmed: 35916593
doi: 10.1097/YIC.0000000000000421
pii: 00004850-202211000-00002
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-241

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M (1983). Bipolar outcome in the course of depressive illness: phenomenologic, familial, and pharmacologic predictors. J Affect Disord 5, 115–128.
Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, et al. (1995). Switching from “unipolar” to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 52, 114–123.
Akiskal HS, Pinto OC, Lara D (2005). “Bipolarity” in the setting of dementia: bipolar type VI. Medscape Family Medecine/Primary Care. http://www.medscape.com/viewarticle/495795 . [Accessed March 2022]
Alexopoulos GS, Young RC, Meyers BS (1993). Geriatric depression: age of onset and dementia. Biol Psychiatry 34:141–145.
Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M (1997). Clinically defined vascular depression. Am J Psychiatry 154:562–565.
Almeida OP, McCaul K, Hankey GJ, Yeap BB, Golledge J, Flicker L (2016). Risk of dementia and death in community-dwelling older men with bipolar disorder. Br J Psychiatry 209:121–126.
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC, American Psychiatric Association.
Angst J, Sellaro R, Stassen HH, Gamma A (2005). Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 84, 149–157.
Baethge C, Gruschka P, Smolka MN, Berghöfer A, Bschor T, Müller-Oerlinghausen B, Bauer M (2003). Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder. J Psychiatry Neurosci 28:355–361.
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ; World Federation of Societies of Biological Psychiatry (WFSBF) Task Force on Treatment Guidelines for Unipolar Depressive Disorders. (2002). World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 3:69–86.
Brodaty H, Luscombe G, Parker G, Wilhelm K, Hickie I, Austin MP, Mitchell P (2001). Early and late onset depression in old age: different aetiologies, same phenomenology. J Affect Disord 66:225–236.
Bukh JD, Bock C, Vinberg M, Gether U, Kessing LV (2011). Differences between early and late onset adult depression. Clin Pract Epidemiol Ment Health 7:140–147.
Bukh JD, Andersen PK, Kessing LV (2016). Rates and predictors of remission, recurrence and conversion to bipolar disorder after the first lifetime episode of depression – a prospective 5-year follow-up study. Psychol Med 46, 1151–1161.
Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS (1995). Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 152:385–390.
Cardoso TA, Mondin TC, Azevedo LB, Toralles LMD, de Mattos Souza LD (2018). Is suicide risk a predictor of diagnosis conversion to bipolar disorder? Psychiatry Res 268:473–477.
Diniz BS, Teixeira AL, Cao F, Gildengers A, Soares JC, Butters MA, Reynolds CF 3rd. (2017). History of bipolar disorder and the risk of dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry 25:357–362.
Dudek D, Siwek M, Zielińska D, Jaeschke R, Rybakowski J (2013). Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review. J Affect Disord 144:112–115.
Duffy A, Goodday S, Keown-Stoneman C, Grof P (2019). The emergent course of bipolar disorder: observations over two decades from the canadian high-risk offspring cohort. Am J Psychiatry 176:720–729.
Gallagher D, Mhaolain AN, Greene E, Walsh C, Denihan A, Bruce I, et al. (2010). Late life depression: a comparison of risk factors and symptoms according to age of onset in community dwelling older adults. Int J Geriatr Psychiatry 25:981–987.
Goodwin FK, Jamison KR(2007). Manic-depressive illness: bipolar disorders and recurrent depression. Oxford University Press.
Gournellis R, Oulis P, Rizos E, Chourdaki E, Gouzaris A, Lykouras L (2010). Clinical correlates of age of onset in psychotic depression. Arch Gerontol Geriatr 52, 94–98.
Grayson L, Thomas A (2013). A systematic review comparing clinical features in early age at onset and late age at onset late-life depression. J Affect Disord 150:161–170.
Guy W (1976). Clinical Global Impression (CGI). ECDEU Assess Man Psychopharmacol 1:125–126.
Herrmann LL, Le Masurier M, Ebmeier KP (2008). White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 79:619–624.
Holma KM, Melartin TK, Holma IA, Isometsä ET (2008). Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5-year prospective study. J Clin Psychiatry 69:1267–1275.
Inoue T, Inagaki Y, Kimura T, Shirakawa O (2015). Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP). J Affect Disord 174:535–541.
Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, Mcdonald Scott P (1987). The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 44, 540–548.
Kessing LV (1999). The effect of the first manic episode in affective disorder: a case register study of hospitalized episodes. J Affect Disord 53, 233–239.
Kessing LV (2006). Differences in diagnostic subtypes among patients with late and early onset of a single depressive episode. Int J Geriatr Psychiatry 21:1127–1131.
Kessing LV, Andersen PK (2017). Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand 135:51–64.
Kessing LV, Willer I, Andersen PK, Bukh JD (2017). Rate and predictors of conversion from unipolar to bipolar disorder: a systematic review and meta-analysis. Bipolar Disord 19:324–335.
Kim EY, Kim NW, Kim MJ, Yang BR, Rhee SJ, Park CHK, et al. (2020). Rate of diagnostic conversion to bipolar disorder in adults with unipolar depression and psychopharmacological treatment in the Republic of Korea: a nationwide register-based study. J Affect Disord 273:240–246.
Krishnan K, Hays J, Tupler L, George L, Blazer D (1995). Clinical and phenomenological comparison of late-onset and early-onset depression. Am J Psychiatry 152, 785–788.
Mendlewicz M (1976). The age factor in depressive illness: some genetic considerations. J Gerontol 31, 300–303.
Musliner KL, Østergaard SD (2018). Patterns and predictors of conversion to bipolar disorder in 91 587 individuals diagnosed with unipolar depression. Acta Psychiatr Scand 137:422–432.
Nakamura K, Iga J, Matsumoto N, Ohmori T (2015). Risk of bipolar disorder and psychotic features in patients initially hospitalised with severe depression. Acta Neuropsychiatr 27:113–118.
Nierenberg AA, Trivedi MH, Fava M, Biggs MM, Shores-Wilson K, Wisniewski SR, et al. (2007). Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. J Psychiatr Res 41:214–221.
O’Donovan C, Garnham JS, Hajek T, Alda M (2008). Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk. J Affect Disord 107:293–298.
Østergaard SD, Straszek S, Petrides G, Skadhede S, Jensen SO, Munk-Jørgensen P, Nielsen J (2014). Risk factors for conversion from unipolar psychotic depression to bipolar disorder. Bipolar Disord 16:180–189.
Päären A, Bohman H, von Knorring L, Olsson G, von Knorring AL, Jonsson U (2014). Early risk factors for adult bipolar disorder in adolescents with mood disorders: a 15-year follow-up of a community sample. BMC Psychiatry 14:363.
Ratheesh A, Davey C, Hetrick S, Alvarez-Jimenez M, Voutier C, Bechdolf A, et al. (2017). A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder. Acta Psychiatr Scand 135:273–284.
Sani G, Perugi G, Tondo L (2017). Treatment of bipolar disorder in a lifetime perspective: is lithium still the best choice? Clin Drug Investig 37:713–727.
Strober M, Lampert C, Schmidt S, Morrell W (1993). The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 32:34–42.
Strober M, Carlson G (1982). Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry 39:549–555.
Tondo L, Visioli C, Preti A, Baldessarini RJ (2014). Bipolar disorders following initial depression: modeling predictive clinical factors. J Affect Disord 167:44–49.
Ulrich LEF, Nogueira EL, Teixeira LM, Ely LS, Filho JCB, Neto AC(2013). Early versus late-onset major depression in the elderly: a comparative study. PAJAR - Pan Am J Aging Res 1, 8–15.
Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, Azevedo Cardoso T (2020). Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand 141, 510–521.
World Health Organization (2004). ICD-10: international statistical classification of diseases and related health problems: tenth revision. 2nd ed. World Heal. ed.

Auteurs

Camilla Elefante (C)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa.

Giulio Emilio Brancati (GE)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa.

Alessandra Petrucci (A)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa.

Teresa Gemmellaro (T)

Department of Psychiatry, North-Western Tuscany Region, NHS Local Health Unit, Viareggio.

Cristina Toni (C)

Institute of Behavioral Science "G. De Lisio".

Lorenzo Lattanzi (L)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Giulio Perugi (G)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa.
Institute of Behavioral Science "G. De Lisio".

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH